BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2910489)

  • 1. Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors.
    Douillard JY; Laborda J; Burg C; Ridge J; Levenbook I; Blottière H; Sela B; Hoffman T
    Cancer Res; 1989 Feb; 49(3):687-92. PubMed ID: 2910489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice.
    Laborda J; Douillard JY; Burg C; Lizzio EF; Ridge J; Levenbook I; Hoffman T
    J Nucl Med; 1990 Jun; 31(6):1028-34. PubMed ID: 2348232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines.
    Laferté S; Prokopishyn NL; Moyana T; Bird RP
    J Cell Biochem; 1995 Jan; 57(1):101-19. PubMed ID: 7536750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
    McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG
    Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
    Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies.
    Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
    Cancer Res; 1986 Jun; 46(6):2970-7. PubMed ID: 3009005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody, CSTO-1, against a stomach adenocarcinoma-associated antigen.
    Togashi H; Terasaki PI; Chia D; Kukes G; Mugishima H; Kasai K; Suyama N; Fukushima K; Hirota M
    Cancer Res; 1984 Sep; 44(9):3952-6. PubMed ID: 6744310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
    J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytotoxic monoclonal antibody to colon adenocarcinoma.
    Kaszubowski PA; Terasaki PI; Chia DS; Kukes GD; Hardiwidjaja SI; Cicciarelli JC
    Cancer Res; 1984 Mar; 44(3):1194-9. PubMed ID: 6362858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
    Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
    Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
    Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
    Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of monoclonal antibodies against tumor associated antigens to improve tumor targeting of LAK cells in a model of rat colon carcinoma.
    Zennadi R; Blottière MH; Burg C; Le Pendu J; Douillard JY
    Bull Cancer; 1993 Aug; 80(8):674-9. PubMed ID: 8204947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
    Sakamoto J; Furukawa K; Cordon-Cardo C; Yin BW; Rettig WJ; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.